AZB & Partners Represented Sun Pharma in Proposed Acquisition of Organon & Co.

Published on May 8, 2026

AZB & Partners represented Sun Pharma in its proposed acquisition of Organon & Co. in an all-cash transaction with an enterprise value of approximately $11.75 billion.